Clinical trial begun of a vaccine to prevent genital herpes

Clinical trial begun of a vaccine to prevent genital herpes

BETHESDA, Md., Nov. 8 (UPI) -- U.S. researchers began an early stage clinical trial of a vaccine to prevent genital herpes disease by removing two key proteins so the virus cannot multiply.
Majority of malaria deaths among small children in Africa

Majority of malaria deaths among small children in Africa

BETHESDA, Md., April 25 (UPI) -- There were 219 million cases of malaria and 660,000 malaria-related deaths globally in 2010, World Health Organizations officials in Switzerland said Thursday.

Dengue fever vaccine shows promise

BETHESDA, Md., Jan. 24 (UPI) -- U.S. scientists at the National Institutes of Health say their dengue vaccine is safe and stimulates a strong immune response in most recipients.

It is possible to lose child egg allergy

BETHESDA, Md., July 20 (UPI) -- Daily doses of egg white powder may help children and teens allergic to eggs overcome their allergy and eat some egg-containing food, U.S. researchers say.

Food allergy rate worse than thought

BETHESDA, Md., June 26 (UPI) -- Seventy-two percent of young children with food allergies have severe food reactions -- a much higher rate than previously thought -- U.S. researchers say.

World TB Day: Drug-resistant TB spreading

BETHESDA, Md., March 24 (UPI) -- One-third of the world's population -- 2 billion people -- are believed to have the organism that causes tuberculosis, U.S. health officials say.
Pregnant women: One dose of H1N1 vaccine

Pregnant women: One dose of H1N1 vaccine

BETHESDA, Md., Nov. 3 (UPI) -- Healthy pregnant women need only one dose of H1N1 influenza vaccine to mount a robust immune response, U.S. health officials say.

H1N1 vaccine trials in HIV-infected people

BETHESDA, Md., Oct. 12 (UPI) -- The first clinical trial of the H1N1 influenza vaccine in human immunodeficiency virus-infected pregnant women has begun, U.S. officials said.

U.S. flu clinical trials set to begin

BETHESDA, Md., July 22 (UPI) -- Preparations are under way to initiate clinical trials to test 2009 H1N1 flu vaccine candidates, U.S. health officials said Wednesday.

AIDS experts go back to basics

WASHINGTON, March 26 (UPI) -- The head of the U.S. agency in charge of AIDS research says scientists need to go back to basics to find a vaccine against the HIV virus.

New understanding of how HIV works

SAN FRANCISCO, Feb. 11 (UPI) -- U.S. government scientists have discovered an important piece of the puzzle in their efforts to learn how the human immunodeficiency virus operates.

Dengue potential U.S. health threat

WASHINGTON , Jan. 9 (UPI) -- U.S. researchers said public health officials need to consider the threat of dengue reaching the United States as a real possibility.

Puzzling results from HIV vaccine trial

WASHINGTON, Dec. 3 (UPI) -- A potential HIV vaccine that recently failed a clinical trial in the United States may increase some people's chance of catching the virus that causes AIDS.

Scientists gain new view of immunity

WASHINGTON, April 17 (UPI) -- U.S. government scientists announced Monday they have gained a new understanding of how long-term immunity works.

Flu vaccine supplies seen as adequate

WASHINGTON, Oct. 25 (UPI) -- Despite some spot shortages, U.S. federal health officials are confident the country's overall flu vaccine supply will be adequate this season.
Page 1 of 3
Anthony S. Fauci
Dr. Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases, appears before the House Government Reform Committee to discuss the nation's flue vacine shortage on Capitol Hill in Washington on Oct. 8, 2004. The supply of flu shots was dramatically cut after a major manufacturer in Great Britain was forced to pull its vaccine due to bacterial contamination. (UPI Photo/Roger L. Wollenberg)

Anthony S. Fauci (born: December 24, 1940) is an immunologist who has made substantial contributions to research in the areas of AIDS and other immunodeficiencies, both as a scientist and as the head of the National Institute of Allergy and Infectious Diseases (NIAID).

Anthony Stephen Fauci was born on December 24, 1940, in Brooklyn, New York, to Stephen A. Fauci, a pharmacist, and Eugenia A. Fauci, a homemaker. He graduated from the all-scholarship, Jesuit-run Regis High School in New York City. He went on to attend the College of the Holy Cross and later received his M.D. from Cornell University Medical College in 1966. He then completed an internship and residency at The New York Hospital-Cornell Medical Center.

In 1968, Fauci came to the National Institutes of Health (NIH) as a clinical associate in the Laboratory of Clinical Investigation (LCI) in NIAID. In 1974, he became Head of the Clinical Physiology Section, LCI, and in 1980 was appointed Chief of the Laboratory of Immunoregulation, a position he still holds. In 1984, Fauci became Director of NIAID, where he oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat infectious and immune-mediated illnesses, including HIV/AIDS and other sexually transmitted diseases, illness from potential agents of bioterrorism, tuberculosis, malaria, autoimmune disorders, asthma and allergies.

This article is licensed under the GNU Free Documentation License.
It uses material from the Wikipedia article "Anthony S. Fauci."
Most Popular
Nick Cannon confirms split from Mariah Carey
South Carolina woman allegedly beats 64-year-old man for farting in her face
George Clooney to marry Amal Alamuddin next month in Italy
Birds lost their sweet tooth, hummingbirds got it back
Gallery: Makeup artist uses her chin as canvas for perfect cartoon renderings